These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37188891)

  • 1. Tackling Counterfeit Drugs: The Challenges and Possibilities.
    Pathak R; Gaur V; Sankrityayan H; Gogtay J
    Pharmaceut Med; 2023 Jul; 37(4):281-290. PubMed ID: 37188891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic.
    Ziavrou KS; Noguera S; Boumba VA
    Forensic Sci Int; 2022 Sep; 338():111382. PubMed ID: 35882074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substandard and counterfeit medicines: a systematic review of the literature.
    Almuzaini T; Choonara I; Sammons H
    BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health consequences of falsified medicines- A study of the published literature.
    Rahman MS; Yoshida N; Tsuboi H; Tomizu N; Endo J; Miyu O; Akimoto Y; Kimura K
    Trop Med Int Health; 2018 Dec; 23(12):1294-1303. PubMed ID: 30291683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The silent development of counterfeit medications in developing countries - A systematic review of detection technologies.
    Bolla AS; Patel AR; Priefer R
    Int J Pharm; 2020 Sep; 587():119702. PubMed ID: 32736015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
    Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
    BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterfeit drugs and medical devices in developing countries.
    Glass BD
    Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.
    Stukina V; Dohnal J; Saloun J
    Acta Pol Pharm; 2016 Sep; 73(5):1381-1388. PubMed ID: 29638079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.